• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

P18 (BFRF3) Recombinant Protein

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS505055

This recombinant antigen is a truncated form of the capsid protein VP26, the putative 18 kDa (VCA), which is codified by the BFRF3 gene of EBV. More details

$1195 / 1 mg +1 FREE 8GB USB
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
p18 (BFRF3), Recombinant Protein
Full Product Name
RECOMBINANT ANTIGEN p18 from Epstein-Barr Virus (EBV)
Product Gene Name
Form/Format
Dry Powder (Stabilized with 5% trehalose)
Preparation and Storage
Lyophilized protein is shipped with on ice packs. Upon arrival, it should be stored at 20 degree C to -80 degree C. Aliquot after reconstitution in order to avoid repeated freezing and thawing cycles and store at 20 degree C to -80 degree C.
Molecular Weight
Determined by SDS-PAGE, the protein band is between molecular markers of 25,000-18,400 Da, while relative molecular mass calculated from amino acid sequence is 15846.1 Da.
Source
Escherichia Coli
Total quantity per aliquot
0.5 mg
Recombinant Antigen
EBV antigen p18 (Wout et al., 1993).
Batch composition
Components: His-p18
Composition: Recombinant antigen with a his-tag in its N-terminus.
Storage buffer before lyohplization: 20mM phosphate bfufer pH 7. 1M NaCl and 0.1% polyoxylethylene (10) tridecylether
Quality Control
PROTEIN CONCENTRATION DETERMINED ESPECTROPHOTOMETRICALLY

DO 280 =0.202
A 0.1%(=1 g/l) = 0.094
CONCENTRATION: 2.15mg/ml

*The meassurement of the protein concentration has been performed with the theoretical extinction coefficient of the recombinant protein obtained from Gill and vonHippel, 1989. It is recommended that the users carry out their absorbance deteminations to avoid equipment variabilities regarding final concentration, mainly in reproducibility analysis.
Lot Specifications
1. RECONSTITUTION: with approx. 0.047 ml of sterile double-distilled water, a final concentration of approx. 2.15 mg/ml will be obtained. The solubilization of the cake should be developed for 15 min to allow a homogeneous protein solution, considering that part of the cake can be on the glass-walls of the container. Upon reconstitution, leave the solution at leas 15 min homogenizing with a mild agitation at 4 degree C. Avoid vigorous shaking that can cause foaming an protein denaturation. With this reconstitution, the protein will be maintained at pH7. It is recommended that the users carry out their absorbance determinations to avoid concentration variabilities due to the equipment used, mainly in reproducibility analysis.
2. TOTAL QUANTITY PER ALIQUOT: 0.1 mg
3. SUGGESTED TITER BY ELISA: up to 1:48,864, which corresponds to 0.044 ug/ml of protein concentration in plates, for IgM detection.
4. STORAGE: Protein is shipped with dry ice. Upon arrival, it should be aliquoted to avoid repeated freezing and thawing cycles and stored at -20ºC to -80ºC.
5. TESTED APPLICATIONS: ELISA.
6. POSIBLE APPLICATIONS: WB, DB, Indirect ELISA, positive control in direct ELISA, CLIA, lateral-flow. Where this product has not been tested for use in a particular technique, this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates.
7. OBSERVATIONS: proteins should be maintained frozen at high concentrations. The dilution to be performed for ELISA assays should be made with a small quantity of protein, the same day of the experiment. In order to defrost the protein, maintain the aliquot at 25ºC without shaking to avoid aggregation. Prior making test dilutions and after defrosting the protein, is recommended to remove possible protein aggregates by centrifuging the stock solution, avoiding alterations in the immobilization of the biomolecule to the solid surface.

Product Categories/Family for BFRF3 recombinant protein

ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Application Notes for BFRF3 recombinant protein
ELISA and Western blot assays. Where this product has not been tested for use in a particular technique,this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates.

Suggested Titer By ELISA: approx. until 1:48.636, which corresponds to 0.044ug/mL of protein concentration in plates, for IgM detection.

SDS-PAGE of BFRF3 recombinant protein

Purity control in SDS-PAGE: 17%
BFRF3 Recombinant Protein – Cat# MBS505055

TITRATION CURVE BY AN ELISA ASSAY of BFRF3 recombinant protein

The titer has been suggested in reference to an "in-house" ELISA kit performed at Rekom Biotech over the first lot obtained.
Each end user should carry out their own titration for their particular application.

Figure 2. In this plot, the optical density at 450/620 nm for positive (blue) and negative (gray) IgM sera are compared for each concentration of the recombinant antigen. An appropriate statistical test of significance for the comparison of means between both groups, the Welch's test, is employed. Eligible concentrations for the use of the antigen should present statistically significant differences between positive and negative sera. This happens when the intervals at the top do not overlap and, equivalently, when the pvalue at the bottom is below 0.05. In the present figure, all p-values are below 0.05 and thus the intervals do not overlap. Therefore, any of the showed concentrations can be used to distinguish between positive and negative sera.
BFRF3 Recombinant Protein, TITRATION CURVE BY AN ELISA ASSAY – Cat# MBS505055

Product References and Citations for BFRF3 recombinant protein

Wout M. J. Van Grunsven, Erika C. Van Heerde, Hans J. W. De Haard, Willy J. M. Spaan and Jaap M. Middeldorp. Gene Mapping and Expression of Two Immunodominant Epstein-Barr Virus Capsid Proteins. 1993, J. of Virology, p. 3908-3916.
Bradford, MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem. 1976, 131:499-503.

Other Notes

Small volumes of BFRF3 recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for BFRF3 purchase

MBS505055 is a recombinant protein targeting BFRF3. Also known as RECOMBINANT ANTIGEN p18 from Epstein-Barr Virus (EBV).

Additional Details

NCBI/Uniprot data below describe general gene information for BFRF3. It may not necessarily be applicable to this product.

Protein Family

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000